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Brain-specific epigenetic markers of schizophrenia
LF Wockner1, CP Morris2, EP Noble3, BR Lawford2, VLJ Whitehall1, RM Young2 and J Voisey2
Epigenetics plays a crucial role in schizophrenia susceptibility. In a previous study, we identified over 4500 differentially methylated
sites in prefrontal cortex (PFC) samples from schizophrenia patients. We believe this was the first genome-wide methylation study
performed on human brain tissue using the Illumina Infinium HumanMethylation450 Bead Chip. To understand the biological
significance of these results, we sought to identify a smaller number of differentially methylated regions (DMRs) of more functional
relevance compared with individual differentially methylated sites. Since our schizophrenia whole genome methylation study was
performed, another study analysing two separate data sets of post-mortem tissue in the PFC from schizophrenia patients has been
published. We analysed all three data sets using the bumphunter function found in the Bioconductor package minfi to identify
regions that are consistently differentially methylated across distinct cohorts. We identified seven regions that are consistently
differentially methylated in schizophrenia, despite considerable heterogeneity in the methylation profiles of patients with
schizophrenia. The regions were near CERS3, DPPA5, PRDM9, DDX43, REC8, LY6G5C and a region on chromosome 10. Of particular
interest is PRDM9 which encodes a histone methyltransferase that is essential for meiotic recombination and is known to tag genes
for epigenetic transcriptional activation. These seven DMRs are likely to be key epigenetic factors in the aetiology of schizophrenia
and normal brain neurodevelopment.
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INTRODUCTION
Schizophrenia is a severe psychiatric disorder and affects 1% of
the population. It has a high heritability of up to 80%1,2 but
despite decades of research, a large proportion of the genetic risk
is still unaccounted for. A number of susceptibility genes located
in neuronal signalling pathways such as dopamine and glutamate
have been identified but the aetiology of schizophrenia remains
largely unknown. Evidence now suggests that epigenetic mod-
ifications play a major role in schizophrenia pathophysiology.
DNA methylation reflects the addition of a methyl group on the
cytosine of CpG dinucleotides. It is one form of epigenetic
modification that regulates gene function, and this may be
mediated through the environment.3 DNA methylation may alter
gene expression by restricting access of transcription factors to
promoter regions or by changing mRNA processing. Even though
these cytosine modifications cannot be seen on the DNA
sequence they can be inherited by offspring. In the past,
schizophrenia DNA methylation studies were focused on periph-
eral tissue, mainly due to the limited access to post-mortem brain
tissue. Our previous study was the first to assess DNA methylation
in post-mortem brain tissue from schizophrenia patients using the
Illumina Infinium HumanMethylation450 Bead Chip.4 In addition
to assessing DNA methylation at CpG islands and promoters, the
chip also measures CpG ‘shores’ and ‘shelves’ which are regions
known to also have altered DNA methylation.5 After adjusting for
age and post-mortem interval, 4641 probes corresponding to
2929 unique genes were differentially methylated. More than 100
of these genes overlap with a DNA methylation study of
peripheral blood from schizophrenia patients.6 Important DNA
methylation changes have been reported in the early stages of
development and suggest that aberrant DNA methylation during
development could be critical for the pathogenesis of
schizophrenia.7 We found that probes in the regions of DNMT1,
NOS1 and SOX10 were differentially methylated in schizophrenia4
and it is known these genes are also differentially methylated from
foetal to neonatal life stage.7
Although methylation of single CpG sites have been shown to
be related to phenotypes8 or gene expression,9 it is believed that
most functionally important findings will be associated with the
methylation of genomic regions.10,11 Until recently there has been
a paucity of algorithms that have identified differentially
methylated regions (DMR) in a statistically robust manner. The
bumphunter function found in the Bioconductor package minfi12
implements a method13 to identify and attach statistical
uncertainty to DMRs in the Infinium HumanMethylation450 array.
Clusters of probes, with the maximum gap between adjacent
probes no more than a defined distance apart, are used to
estimate a smoothed estimate of the level of methylation across
the region. Unlike other DMR detection algorithms designed for
the 450K array,14,15 the bumphunter function determines candi-
date DMR based on a resampling procedure and adjusts for other
covariates such as age and sex.16 In conjunction with genomic
annotation, it is hypothesised that DMR will provide a more
meaningful understanding of the impact of methylation on the
development of specific phenotypes.10
Despite an increasing number of studies that have looked at
methylation patterns in schizophrenia patients the results have
been inconsistent. This is potentially due to the heterogeneity of
schizophrenia or the different tissue samples investigated. Since
our schizophrenia whole genome methylation study was
performed, another study analysing two distinct sets of post-
mortem tissue in the prefrontal cortex (PFC) from schizophrenia
patients has been published.17 The analysis of this data in
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conjunction with our previously published data enables identifica-
tion of those regions that are consistently differentially methylated
across distinct cohorts. Identification of these regions may
improve our understanding of the molecular mechanisms under-
lying schizophrenia.
MATERIALS AND METHODS
Samples
Frontal cortex post-mortem brain tissue from individuals with DSM-IV
(Diagnostic and Statistical Manual of Mental Disorders, 4th edition)
diagnosed schizophrenia (n=24) and controls (n= 24) was provided by
the Human Brain and Spinal Fluid Resource Centre (HBSFRC; courtesy of
James Riehl). Participants gave written consent through the HBSFRC for
their brain tissue to be used for research into etiopathogenesis of human
disease. Each sample consisted of a coronal section (7-mm thick) that had
been quick frozen and a section of frontal cortex was dissected from each
frozen section sample weighing 0.4–1.0 g. Extraction of DNA was
performed at the UCLA Clinical Microarray Core Laboratory using the
Roche MagNa Pure Compact (Roche, San Francisco, CA, USA). Ethics
approval for the project was obtained from the Human Research Ethics
Committee of the Queensland University of Technology.
Illumina infinium humanmethylation450 beadchip
DNA samples were sent to the Australian Genome Research Facility (AGRF)
and stored at − 20 ºC. Quality checking of the samples was performed by
Nanodrop Spectrophotometer (Nanodrop, Wilmington, DE, USA) and
resolution on a 0.8% agarose gel. Samples were bisulphite converted with
Zymo EZ DNA Methylation kit (Zymo Research, Irvine, CA, USA).
GenomeStudio v2011.1 (Illumina, San Diego, CA, USA) with methylation
module 1.9.0 software (Illumina), with the default Illumina settings and
Illumina HumanMethylation450_15017482_v.1.2 manifest files was used in
the methylation analysis. The Infinium platform assays 4485 000 CpG
sites, encompassing 99% of RefSeq genes. It covers 96% of CpG islands
with multiple sites in the island, the shores (within 2 kb from CpG islands)
and the shelves (42 kb from CpG islands). It also covers CpG sites outside
of CpG islands and DNase hypersensitive sites as well as incorporating
miRNA promoter regions. All the Illumina quality controls were found to be
in order which included sample-independent controls, sample-dependent
controls, staining controls, extension controls, target removal controls,
hybridisation controls, bisulphite conversion I and II controls, specificity
controls, non-polymorphic controls and negative controls.
Data processing
For methylation analysis, IDAT files were loaded into the R (3.2.1)18
environment using the Bioconductor (http://www.bioconductor.org) minfi
package 1.14.0.12 Quality control measures were assessed and no outlier
samples were detected. One sample was removed from further analysis as
age and post-mortem interval was not available. Data-driven sex values
were recorded for all samples using the getSex function in the minfi
package. In one instance it was ambiguous as to what the true gender was;
hence this sample was excluded from further analysis.
The arrays were then background and control normalised using the
minfi package; this is roughly equivalent to the normalisation procedure in
Genome Studio (Illumina). Finally, technical differences between Infinium I
and Infinium II probes were removed using Subset-quantile Within Array
Normalisation (SWAN), developed by Maksimovic et al.19 and available in
the minfi package. The methylation status for each probe was recorded
as a beta value that ranged between 0 and 1, where values close to 1
represent high levels of methylation and where values close to 0 represent
low levels of methylation.
A detection P-value was calculated for all probes on all arrays.
A P-value40.05 indicates that the data point is not significantly different
from background measurements. A total of 13 764 probes were removed
from the analysis as at least one sample had a detection P-value40.05. We
removed probes that had an annotated SNP (dbSNP134) at the single-base
extension (position 0) or CpG site (positions 1–2) as it is possible that SNP
differences in these locations may manifest as differential methylation on
the 450k array. All probes on the X and Y chromosome were also removed.
The data are referred to as the HBSFRC data set (GEO accession number
GSE61107).
Publicly available data
PFC data. The processed and normalised beta values for two data sets
described in the study by Pidsley et al.17 were downloaded from the Gene
Expression Omnibus (GEO); these were the London Brain Bank for
Neurodegenerative Disorders (LBBND data set; GEO accession number
GSE61431) and the Douglas Bell-Canada Brain Bank, Montreal (DBCBB data
set; GEO accession number GSE61380). From these data sets, the
methylation beta values from the PFC only were extracted. For the LBBND
data set there were 20 schizophrenia cases and 23 controls (after the
exclusion criteria as in the study by Pidsley et al.17 was applied); and for the
DBCBB data set there were 18 schizophrenia cases and 15 controls. The
downloaded data set was pre-processed and normalised according to the
study by Pidsley et al.17 using the dasen function described in Pidsley
et al.20 All probes on the X and Y chromosome were also removed. The
main difference between the procedures is that we do not perform any
between-array normalisation. Aryee et al.12 indicate that their version of
stratified normalisation ‘is not recommended for cases where global
changes are expected, such as in cancer–normal comparisons.’ However,
they do note that the function dasen does decrease the between-array
variability. Ultimately, we were concerned that between-array normal-
isation would remove biological, rather than technical variability.
Assessment of cell composition differences
The CETS package in R21 was used to estimate the proportion of neuronal
cells in the samples. As the proportion of estimated neuronal cells was
significantly different in the HBSFRC and LBBND data sets (Supplementary
Table 1), the top 10 000 probes known to be epigenotype-specific marks
for brain cells21 were removed from the analysis in all three data sets.
Differentially methylated region detection
To assess DMRs between groups, we adapted the bump-hunting
technique previously described13 to the 450k array. Probes were assigned
to clusters so that two neighbouring probes in the same cluster are
separated by at most 500 bp. For each probe, we estimated the difference
in the average logit of the beta values (otherwise known as M-values; as
recommended by Du et al.22) between cases and controls, adjusted for sex,
age and post-mortem interval, when available, and smoothed these
estimated differences using running medians. For all data, an empirical
distribution was created by performing 1000 bootstrap samples and
candidate regions were chosen based on whether the smoothed
estimated differences were greater than the 95% quantile of the empirical
distribution. This resulted in cut-offs of 0.097, 0.124 and 0.224 for the
LBBND, DBCBB and HBSFRC data sets, respectively. The GenomicRanges
package in R23 was used to assess whether any of the significant hyper-
DMR or hypo-DMR overlapped by at least 2 bp in all three PFC data sets.
Sensitivity analysis
A sensitivity analysis was additionally performed to assess the difference in
significant DMRs using a 97.5% cut-off for all data sets. In addition, probes
were assigned to clusters so that two neighbouring probes in the same
cluster are separated by at most 1000 bp (instead of 500 bp) using a
threshold of both 95 and 97.5%. Finally, to investigate the sensitivity to cell
composition, the 10 000 probes known to be epigenotype-specific marks
for brain cells were included in the analysis using both a maximum gap of
500 and 1000 bp gap between adjacent probes.
Annotation of regions
Data were plotted using the Gviz package in R24 and the CpG Islands and
known genes were downloaded for the USCS Browser. Regions were
further annotated using the matchGenes function in the minfi package.
RESULTS
Differentially methylated regions in the HBSFRC data set
In the HBSFRC data set, 6868 candidate DMR were identified
(cut-off M-value 0.224) and of these, 1550 DMR had a Po0.05
where P is the nominated false discovery rate. When the P-values
were adjusted such that the family-wise error rate was o0.1 three
regions were differentially methylated (Table 1). RNF39 was found
to be significantly differentially hypomethylated in the DBCBB
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data set when controlling the FDRo0.05 (ΔM=− 0.235; P= 0.005);
however, was not significantly differentially methylated in the
LBBND data set (ΔM=− 0.137; P= 0.173), despite being chosen as
a candidate region.
Overlapping DMRs in publicly available data sets
Using the LBBND data set 4120 candidate DMR were identified
(cut-off M-value 0.097) and of these 596 had a Po0.05. Using the
DBCBB data set 2172 candidate DMR were identified (cut-off M-
value 0.124) and of these 296 had Po0.05. Full annotated lists of
candidate regions for each data set are provided in the
Supplementary Material (Supplementary Tables 2–4).
The significantly hyper- and hypomethylated regions were
compared for overlaps. Figure 1 details the degree of the
overlapping regions in the PFC data sets. Five regions were
significantly hyper-methylated in all three PFC data sets (Table 2).
Two regions were significantly hypomethylated in all three data
sets (Table 2).
When these regions were annotated with known reference
genes and CpG Islands from the UCSC browser, most regions were
differentially methylated either upstream of, or on, the first exon
of: Developmental Pluripotency Associated 5 (DPPA5), DDX43
(Figures 2a and b); Ceramide Synthase 3 (CERS3), PRDM9
(Figures 3a and b) and REC8 (Supplementary Figure 1). One
region was located on a CpG Island on chromosome 6 located in
LY6G5C (Supplementary Figure 2) and another on chromosome
10, 131 kb upstream of the nearest gene PFKP (Supplementary
Figure 3). More detailed annotation can be seen in Supplementary
Table 5.
Sensitivity analysis
When the maximum allowable gap between adjacent probes was
changed from 500 to 1000 bp all seven regions remained
significantly differentially methylated. Two additional regions near
Piwi-Like RNA-Mediated Gene Silencing 1 (PIWIL1) and Succinate
Dehydrogenase Complex, Subunit A, Flavoprotein Pseudogene 3
(SDHAP3) were also identified as being differentially methylated in
all three data sets. When the M-value cut-off was defined to be
greater than the 97.5% quantile of the empirical distribution, only
the region near CERS3 remained significant in all three data sets.
However, PRDM9, DDX43, LY6G5C and the region on chromosome
10 had adjusted P-valueso0.1 in all data sets. DPPA5 was
significant in two data sets (Po0.05) but had P= 0.119 in the
HBSFRC data set. REC8 was not selected as a candidate region.
Including the 10 000 probes known to be epigenotype-specific
marks for neuronal cells made no discernible difference to the
overlapping regions. Full details about overlapping candidate
regions for all sensitivity analyses can be seen in Supplementary
Table 6.
DISCUSSION
Using three publicly available data sets (including our study) that
investigated tissue from the PFC of the brain, we have been able
to identify seven regions that are consistently differentially
methylated in schizophrenia. Six of these regions are located
upstream or in exons of CERS3, DPPA5, REC8, PRDM9, LY6G5C and
DDX43. One region on chromosome 10 is located more than
130 kb outside of the nearest gene PFKP. This region lies within a
DNase hypersensitive site identified from the ENCODE project,25
suggesting it could be a marker of regulatory DNA.
The known characteristics of the three data sets presented here
can be seen in Supplementary Table 7. All three data sets are not
only geographically distinct but also cover a wide distribution of
ages. The only substantial commonality is the diagnosis of
schizophrenia. Thus, it can be expected that any differentially
methylated overlapping regions represent the strongest evidence
of schizophrenia-related methylation.
The DMRs associated with schizophrenia across all three brain
data sets include biologically relevant regions that may explain
some of the schizophrenia aetiology and represent genes
important in neurodevelopment. PRDM9 encodes a histone
Table 1. The average difference in M-values in those regions with a FWER o0.1 in HBSFRC data set
Chr Start End Average ΔM FDR FWER Nearest gene
chr13 100640914 100644657 0.624 1.8E− 06 0.005 ZIC2
chr20 36148604 36149455 0.490 5.7E− 06 0.015 BLCAP
chr6 30042137 30043924 − 0.392 2.5E− 05 0.065 RNF39
Abbreviations: FDR, false discovery rate; FWER, family-wise error rate; HBSFRC, Human Brain and Spinal Fluid Resource Centre.
Figure 1. Summary of number of overlapping regions between the
three prefrontal cortex data sets. DBCBB, Douglas Bell-Canada Brain
Bank; HBSFRC, Human Brain and Spinal Fluid Resource Centre;
LBBND, London Brain Bank for Neurodegenerative Disorder.
Table 2. The average difference in M-values in regions consistently
differentially methylated in all three prefrontal cortex data sets
Chr Average ΔM
(HBSFRC)
Average ΔM
(LBBND)
Average ΔM
(DBCBB)
Nearest
gene
chr5 0.351 0.153 0.306 PRDM9
chr6 0.314 0.240 0.267 DPPA5
chr6 0.394 0.219 0.318 DDX43
chr6 − 0.263 − 0.156 − 0.191 LY6G5C
chr10 0.365 0.286 0.241 PFKP
chr14 − 0.368 − 0.129 −0.150 REC8
chr15 0.715 0.269 0.301 CERS3
Abbreviations: DBCBB, Douglas Bell-Canada Brain Bank; HBSFRC, Human
Brain and Spinal Fluid Resource Centre; LBBND, London Brain Bank for
Neurodegenerative Disorders.
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methyltransferase that specifically trimethylates H3K4 (Lys-4 in
histone H3). Methylation of H3K4 is known to specifically ‘tag’
genes for epigenetic transcriptional activation.26,27 PRDM9 is
expressed in germ cells during meiotic prophase and its
disruption inhibits prophase progression leading to sterility.28
Meiotic recombination events cluster into narrow segments of the
genome, defined as hotspots and PRDM9 plays a role in
determination of these recombination hotspots.29–31 In the past
PRDM9 was not on the radar as a schizophrenia candidate gene as
genomic alterations that occur during meiosis are not detected
using standard genetic mapping techniques. Future large scale
studies that have access to pedigree information may uncover
parent of origin effects.
The second DMR identified is located in the promoter region of
a gene also important in meiosis. Meiotic recombination protein
REC8 encodes a member of the kleisin family of structural
maintenance of chromosomes protein partners. REC8 localises to
the axial elements of chromosomes during meiosis in oocytes and
spermatocytes.32 REC8 was mapped to chromosomes 14q11.2-
12,32 which is a potential schizophrenia susceptibility locus.33
DDX43 encodes an ATP-dependent RNA helicase in the DEAD-
box family. DDX43 is implicated in sex-specific autosomal
patterns34 and is thought to play a role in spermatogenesis.35
The region we identified in DDX43 is also located within a CpG
Island. DPPA5 encodes an RNA-binding protein that is highly
expressed in undifferentiated pluripotent stem cells and has an
early embryo-specific expression pattern.36 The DMR we identified
within DPPA5 lies in a CpG Island. Another region that is
differentially methylated in all three studies and lies within a
CpG island is CERS3. CERS3 contributes to the fatty acid
composition and concentration of ceramides in the epidermis
and male germ cells.37,38 Although an association with schizo-
phrenia has not been previously reported, ceramides are
important in embryogenesis.38,39 A deletion in this gene leads to
autosomal recessive congenital skin disorder called ichthyosis.40
The DMR within LY6G5C also lies within a CpG island. Lymphocyte
antigen-6 complex belongs to a cluster of leucocyte antigen-6
(LY6) genes located in the MHC class III region.41 MHC encodes
400 genes critical to immune system function and is strongly
associated with schizophrenia susceptibility.42
A sensitivity analysis was also applied to the data allowing a
1000-bp gap between adjacent probes. All of the seven DMRs
remained significant but two additional regions near PIWIL1 and
SDHAP3 were also significantly differentially methylated in all
three data sets. SDHAP3 is a pseudogene and no information is
available for the gene function. Interestingly, a region in this gene
has been found to be differentially methylated in cerebellar tissue
in an autism study.43 The autism study identified the DMR to be an
important regulatory site from its location within a CCCTC factor-
binding site.43 PIWIL1 plays an important role in stem cell self-
renewal, RNA silencing and translational regulation.44 More
recently PIWIL1 has been shown to play a crucial role in neuronal
development.45 PIWIL1 regulates polarisation and radical migra-
tion of newborn neurons in the developing cerebral cortex45 and
copy number variations in this gene are associated with autism
spectrum disorders.46
As a previous study has shown that the two major cell types,
neurons and glia, have different DNA methylation signatures,47 we
Figure 2. HBSFRC data set (blue axis), LBBND data set (red axis), DBCBB (green axis) with unadjusted beta values for the control (blue +) and
schizophrenia groups (pink x) and the average difference in M-values for each probe; the width of the red highlighted area represents the
identified differentially methylated regions, while the height of the region represents the average difference in M-values across the region. The
yellow axis represents the known genes downloaded for UCSC browser and the green boxes represent known CpG islands: (a) region near
DPPA5; (b) region near DDX43. DBCBB, Douglas Bell-Canada Brain Bank; HBSFRC, Human Brain and Spinal Fluid Resource Centre; LBBND,
London Brain Bank for Neurodegenerative Disorder.
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estimated the proportion of neuronal cells for each sample. Due to
significant differences in cell composition in the HBSFRC and
LBBND data sets between cases and controls, 10 000 probes
known to be epigenotype-specific marks for neuronal cells21 were
removed from all data sets. In addition, given that the proportion
of neuronal cells was higher in the cases (compared with controls)
in the LBBND data set, but lower in the cases (compared with
controls) in the HBSFRC data set and approximately equal in the
DBCBB data set, it is unlikely that the seven regions are
consistently differentially methylated due to differences in cell
composition.
Although different data normalisation techniques were used for
the publically available data sets, the identification of seven
significant DMRs points to the robustness of the results. Despite
the considerable heterogeneity in the methylation profiles of
patients with schizophrenia, consistent results were identified.
The seven regions identified as differentially methylated from
three independent sample sets could potentially establish a causal
role in the pathology of schizophrenia-associated epigenetic
modifications.
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